Atlas Trials

Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects

Clinical trial NCT01755442 · TERMINATED

Trial details

NCT number
NCT01755442
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2012-11-01
Primary completion
2013-01-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.